These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 34772429)

  • 1. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein.
    Lakso M; Vartiainen S; Moilanen AM; Sirviö J; Thomas JH; Nass R; Blakely RD; Wong G
    J Neurochem; 2003 Jul; 86(1):165-72. PubMed ID: 12807436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration.
    Mor DE; Daniels MJ; Ischiropoulos H
    Mov Disord; 2019 Feb; 34(2):167-179. PubMed ID: 30633814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
    Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
    J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
    Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
    Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans.
    Cao P; Yuan Y; Pehek EA; Moise AR; Huang Y; Palczewski K; Feng Z
    PLoS One; 2010 Feb; 5(2):e9312. PubMed ID: 20174477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Butoxytetrahydrofuran, Isolated from
    Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
    ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
    Lee SH; Han YT; Cha DS
    Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans.
    Kaur S; Sammi SR; Jadiya P; Nazir A
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease.
    Marques CR; Pereira-Sousa J; Teixeira FG; Sousa RA; Teixeira-Castro A; Salgado AJ
    Cytotherapy; 2021 Oct; 23(10):894-901. PubMed ID: 34059421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration.
    Mor DE; Tsika E; Mazzulli JR; Gould NS; Kim H; Daniels MJ; Doshi S; Gupta P; Grossman JL; Tan VX; Kalb RG; Caldwell KA; Caldwell GA; Wolfe JH; Ischiropoulos H
    Nat Neurosci; 2017 Nov; 20(11):1560-1568. PubMed ID: 28920936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections of
    Kitisin T; Muangkaew W; Sukphopetch P
    Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models.
    Chen M; Vincent J; Ezeanii A; Wakade S; Yerigenahally S; Mor DE
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35790300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.